Hydrochloric Acid

Hydrochloric Acid

SCHEMBL3671969

CCCCCCCCC1=C([Zr+2]C2=C(CCCCCCCC)C=CC2)CC=C1.[Cl-].[Cl-]

nearest known ligand 0.33

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE known ✓ P22303 2/20 0.33
SLC6A2 known ✓ P23975 2/20 0.32
SLC6A3 known ✓ Q01959 2/20 0.32
CHRM2 known ✓ P08172 1/20 0.32
CHRM1 known ✓ P11229 1/20 0.32
CHRM3 known ✓ P20309 1/20 0.32
LIPG Q9Y5X9 1/20 0.33
BACE1 P56817 1/20 0.33
PTGS2 P35354 3/20 0.32
ESR1 P03372 2/20 0.32
ADRA2A P08913 2/20 0.32
ADORA3 P0DMS8 2/20 0.32
TACR2 P21452 2/20 0.32
SLC6A4 P31645 2/20 0.32
KCNH2 Q12809 2/20 0.32
KDM4E B2RXH2 1/20 0.32
ALDH1A1 P00352 1/20 0.32
LMNA P02545 1/20 0.32
SHBG P04278 1/20 0.32
TP53 P04637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL616915 1.00 ACHE (0.33) ACHELIPGBACE1PTGS2ESR1
Hydrochloric Acid SCHEMBL3774056 1.00 ACHE (0.33) ACHELIPGBACE1PTGS2ESR1
Hydrochloric Acid SCHEMBL21854563 1.00 ACHE (0.33) ACHELIPGBACE1PTGS2ESR1
Hydrochloric Acid SCHEMBL1477552 1.00 ACHE (0.33) ACHELIPGBACE1PTGS2ESR1
Hydrochloric Acid SCHEMBL3682818 0.98 TDP1 (0.30) ACHELIPGBACE1
Hydrochloric Acid SCHEMBL78660 0.93
Hydrochloric Acid SCHEMBL4475590 0.91
Ethylene SCHEMBL2047134 0.89
SCHEMBL3842777 0.89
Fluoride Ion SCHEMBL1130833 0.89

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7323524-B2 Tandem tetramerisation-polymerisation of olefins SASOL TECHNOLOGY (PTY) LIMITED (ZA) 2008-01-29 US claimed
US-20060128910-A1 Tandem tetramerisation-polymerisation of olefins SASOL TECHNOLOGY (PTY) LIMITED (ZA) 2006-06-15 US claimed
US-8227392-B2 Base stocks and lubricant blends containing poly-alpha olefins EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2012-07-24 US disclosed
US-20100323937-A1 Base stocks and lubricant blends containing poly-alpha olefins EXXONMOBIL RESEARCH AND ENGINEERING COMPANY 2010-12-23 US disclosed
EP-1517928-B1 SUPPORTED HYBRID METALLOCENE CATALYST, METHOD FOR PREPARING THE SAME, AND METHOD FOR PREPARING POLYOLEFIN USING THE SAME LG CHEMICAL LTD (KR) 2010-11-10 EP disclosed
US-20090131705-A1 Practical, Cost-Effective Synthesis of Ubiquinones ZYMES, LLC 2009-05-21 US disclosed
EP-1968608-A2 PRACTICAL, COST-EFFECTIVE SYNTHESIS OF UBIQUINONES Zymes, LLC (US) 2008-09-17 EP disclosed
US-20080086013-A1 CARBOMETALLATION OF ALKYNES AND IMPROVED SYNTHESIS OF UNIQUINONES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2008-04-10 US disclosed
WO-2008019196-A2 CARBOMETALLATION OF ALKYNES AND IMPROVED SYNTHSIS OF UBIQUINONES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2008-02-14 WO disclosed
US-7323524-B2 Tandem tetramerisation-polymerisation of olefins SASOL TECHNOLOGY (PTY) LIMITED (ZA) 2008-01-29 US disclosed
US-7294600-B2 Supported hybrid metallocene catalyst, method for preparing the same, and method for preparing polyolefin using the same LG CHEM, LTD. (KR) 2007-11-13 US disclosed
US-5567777-A CONTAINING AN ALPHA-OLEFIN; TRANSPARENCY MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1996-10-22 US disclosed
US-5567776-A BLEND ELASTOMERIC COPOLYMERS CONTAINING ALPHA- AND CYCLO-OLEFINS; IMPACT STRENGTH, TRANSPARENCY, FIBER OPTICS MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1996-10-22 US disclosed
EP-0691354-A1 Unsaturated copolymer of ethylene and process for preparing the same MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1996-01-10 EP disclosed
US-5470919-A Seals with ozone resistance, heat aging resistance, oil resistance and weatherproofing MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1995-11-28 US disclosed
EP-0638594-A1 Chlorinated ethylene/alpha-olefin copolymer rubber and composition containing the same MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1995-02-15 EP disclosed
EP-0597119-A1 CYCLOOLEFIN COPOLYMER COMPOSITION AND PRODUCTION THEREOF MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1994-05-18 EP disclosed
EP-0303519-B1 POLYMERIZATION OF ETHYLENE MITSUBISHI PETROCHEMICAL CO., LTD. (JP) 1993-03-31 EP disclosed
US-4931517-A Polymerization of ethylene MITSUBISHI PETROCHEMICAL COMPANY LIMITED (JP) 1990-06-05 US disclosed
EP-0303519-A1 Polymerization of ethylene MITSUBISHI PETROCHEMICAL CO., LTD. (JP) 1989-02-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080086013-A1 CARBOMETALLATION OF ALKYNES AND IMPROVED SYNTHESIS OF UNIQUINONES NDUFA10, NDUFB10, NDUFV1 ACHE 2797/4885SLC6A2 2973/4885SLC6A3 2411/4885
US-20090131705-A1 Practical, Cost-Effective Synthesis of Ubiquinones SQOR, NDUFS6, NDUFS5 ACHE 1412/4885SLC6A2 1929/4885SLC6A3 1696/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.